112 research outputs found

    Attaching DNA to Nanoceria: Regulating Oxidase Activity and Fluorescence Quenching

    Get PDF
    This document is the Accepted Manuscript version of a Published Work that appeared in final form in Applied Materials and Interfaces copyright © American Chemical Society after peer review and technical editing by publisher. To access the final edited and published work see Pautler, R., Kelly, E. Y., Huang, P.-J. J., Cao, J., Liu, B., & Liu, J. (2013). Attaching DNA to Nanoceria: Regulating Oxidase Activity and Fluorescence Quenching. ACS Applied Materials & Interfaces, 5(15), 6820–6825. https://doi.org/10.1021/am4018863Cerium oxide nanoparticles (nanoceria) have recently emerged as a nanozyme with oxidase activity. In this work, we present a few important interfacial properties of nanoceria. First, the surface charge of nanoceria can be controlled not only by adjusting pH but also by adsorption of simple inorganic anions. Adsorption of phosphate and citrate gives negatively charged surface over a broad pH range. Second, nanoceria adsorbs DNA via the DNA phosphate backbone in a sequence-independent manner; DNA adsorption inhibits its oxidase activity. Other anionic polymers display much weaker inhibition effects. Adsorption of simple inorganic phosphate does not have the inhibition effect. Third, nanoceria is a quencher for many fluorophores. These discoveries provide an important understanding for further use of nanoceria in biosensor development, materials science, and nanotechnology.University of Waterloo || Canadian Foundation for Innovation || Natural Sciences and Engineering Research Council || Ontario Ministry of Research and Innovation |

    PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

    Get PDF
    Combined MAPK/PI3K pathway inhibition represents an attractive, albeit toxic, therapeutic strategy in oncology. Since PTEN lies at the intersection of these two pathways, we investigated whether PTEN status determines the functional response to combined pathway inhibition. PTEN (gene, mRNA, and protein) status was extensively characterized in a panel of cancer cell lines and combined MEK/mTOR inhibition displayed highly synergistic pharmacologic interactions almost exclusively in PTEN-loss models. Genetic manipulation of PTEN status confirmed a mechanistic role for PTEN in determining the functional outcome of combined pathway blockade. Proteomic analysis showed greater phosphoproteomic profile modification(s) in response to combined MEK/mTOR inhibition in PTEN- loss contexts and identified JAK1/STAT3 activation as a potential mediator of synergistic interactions. Overall, our results show that PTEN-loss is a crucial determinant of synergistic interactions between MAPK and PI3K pathway inhibitors, potentially exploitable for the selection of cancer patients at the highest chance of benefit from combined therapeutic strategies

    Study of liver Disorders during pregnancy and fetomaternal outcome in a tertiary care hospital

    No full text
    Background: Liver disease in pregnancy encompasses a spectrum of diseases which causes abnormal liver function tests. The liver disorders are associated with significant maternal and foetal morbidity and mortality. The present study was done with objective to study incidence, clinicopathological correlation of liver disorder during pregnancy and its impact on maternal and foetal outcome.Methods: This prospective observational study was conducted in Department of Obstetrics and Gynaecology, NSCB Medical College Jabalpur. Eighty-five antenatal cases, on the basis of inclusion criteria were studied prospectively. Those subjected to detailed history and examination, clinical symptoms suggestive of liver disorders followed by all available LFTs including LDH along with some more definitive tests to aid identification of underlying cause and followed up till delivery in terms of maternal and foetal outcome. Results: The incidence of the liver disorders in pregnancy was 0.86%. In study group, 76.5% cases were between 20-30 years of age,72.9% cases were primigravida and 90.59% cases presented in third trimester of pregnancy. In this study, 76.4% presented with pregnancy specific liver disorder, of these 32.9% had pre-eclampsia, 11.7% had eclampsia, 11.7% had HELLP syndrome. 16.4% with ICP, AFLP 2.3%and Hyperemesis gravidarum in 1.1% cases. Maternal mortality was 10.58% and morbidity was 34.12%. Live birth 61%, still birth 38.82%, preterm 21.1% and IUGR 24.7%. NICU admission required in 28.57% cases. Conclusions: Regular antenatal check-up, screening and diagnosing liver disorder at an earliest, proper treatment and timely referral to higher centres can save the lives of many mothers and foetuses

    Not Available

    No full text
    Not AvailableNot AvailableNot Availabl
    • …
    corecore